Dissolution and uniformity of content of tablets developed with extract of Ximenia americana L.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • Publication Information:
      Original Publication: San Francisco, CA : Public Library of Science
    • Subject Terms:
    • Abstract:
      Herbal medicines currently represent an important part of the world pharmaceutical market, which shows growing interest in the use of herbal medicines. However, the production of such medicines involves a complex series of steps, which determine the production viability and the quality of the final product. Ximenia americana L. is a plant occurring in several regions of the world, with well-known and applied medicinal properties. Thus, the aim of this work was to develop and evaluate the physical and physical-chemical quality of tablets produced with X. americana L. extract. The extract was spray-dried from a hydroethanolic extractive solution and characterized as to its phytochemical composition. The chemical marker was determined and quantified using validated chromatographic methods. These methods indicated the presence of gallic acid at a concentration of 1.61 mg g(-1). Formulations were proposed and analyzed for their flow and compaction properties. The best formulation was used to obtain a batch of tablets, which was evaluated for its quality characteristics and showed to be within the pharmacopoeial specifications for average weight, hardness, friability, and disintegration time. The dissolution profile of the tablets produced was obtained, showing the release of about 70% of the vegetable extract content within 30 minutes. Results showed that it was possible to obtain herbal tablets containing a high content of vegetal extract by direct compression, developing a rapid process of formulation and production and guaranteeing the quality characteristics of the final product.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      J Control Release. 2004 Jul 7;97(3):441-52. (PMID: 15212876)
      PLoS One. 2016 May 18;11(5):e0155532. (PMID: 27192209)
      Pharm Res. 2012 Oct;29(10):2765-76. (PMID: 22315020)
      Mol Pharm. 2011 Aug 1;8(4):1362-71. (PMID: 21696180)
      J Ethnopharmacol. 2010 Sep 15;131(2):326-42. (PMID: 20621178)
      J Chem Ecol. 1993 Apr;19(4):613-21. (PMID: 24249005)
      Evid Based Complement Alternat Med. 2012;2012:681207. (PMID: 22719786)
    • Accession Number:
      0 (Excipients)
      0 (Phytochemicals)
      0 (Plant Extracts)
      0 (Powders)
      0 (Tablets)
    • Publication Date:
      Date Created: 20180526 Date Completed: 20181211 Latest Revision: 20241108
    • Publication Date:
      20241108
    • Accession Number:
      PMC5993115
    • Accession Number:
      10.1371/journal.pone.0197323
    • Accession Number:
      29795592